Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02770768 · ClinicalTrials.gov registry record · NA
Effects of Flibanserin on the Pre- and Post-menopausal Female Brain
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT02770768 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 57 participants.
The verdict
NCT02770768, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
The purpose of the present study is to understand the neurobiological mechanisms of action underlying sexual desire building on prior work Dr. Stephanie Cacioppo has done in which desire was not manipulated. In the present project, Dr. Stephanie Cacioppo is manipulating desire through Flibanserin (Addyi) vs. placebo and she will be measuring subjective sexual desire as a manipulation check. The investigators will address this goal using a double-blind randomized outpatient design and determine the pre-post neurobehavioral change in the Flibanserin group and investigate the extent to which Flibanserin normalizes brain activity in premenopausal women with HSDD and the extent to which regional brain activation is associated with changes in symptoms and behavior (as measured with self-report measures of sexual desire and/or eye-tracking movements).
Interventions
- DRUG Placebo
- DRUG Flibanserin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-10 |
| Est. Completion | 2021-12-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02770768
The ClinicalTrials.gov registry entry for NCT02770768 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02770768 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02770768 about?
NCT02770768 is a clinical study titled "Effects of Flibanserin on the Pre- and Post-menopausal Female Brain". The purpose of the present study is to understand the neurobiological mechanisms of action underlying sexual desire building on prior work Dr. Stephanie Cacioppo has done in which desire was not manipulated. In the present project, Dr. Stephanie Cacioppo is manipulating desire through Flibanserin (A...
What is the current status of trial NCT02770768?
This trial is currently terminated. It is a NA study. The enrollment target is 57 participants. The study started on 2016-10. Estimated completion is 2021-12-21.
What interventions are being tested in trial NCT02770768?
The interventions under investigation include: Placebo (DRUG), Flibanserin (DRUG).
Who is sponsoring clinical trial NCT02770768?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.